T-bet and Eomesodermin Play Critical Roles in Directing T Cell Differentiation to Th1 versus Th17

被引：97

作者：

Yang, Yu ^{[1
,4
]}

Xu, Jiangnan ^{[1
]}

Niu, Yanyan ^{[1
]}

Bromberg, Jonathan S. ^{[1
,2
,3
,4
]}

Ding, Yaozhong ^{[1
,2
,3
,4
]}

机构：

[1] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA

[2] Mt Sinai Sch Med, Dept Surg, New York, NY 10029 USA

[3] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA

[4] Mt Sinai Sch Med, Recanati Miller Transplantat Inst, New York, NY 10029 USA

来源：

JOURNAL OF IMMUNOLOGY | 2008年 / 181卷 / 12期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.4049/jimmunol.181.12.8700

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Th1 and Th17 cells are crucial in immune regulation and autoimmune disease development. By adding Stat6 deficiency to T-bet deficiency, and thus negating effects from elevated levels of IL-4/Stat6/GATA3 Th2 signals in T-bet-deficient cells, we investigated the signals important for Th1 and Th17 cell differentiation and their role in colitis development. The data reveal that Eomesodermin compensates T-bet deficiency for IFN-gamma and Th1 development. However, without T-bet, IFN-gamma production and Th1 differentiation are susceptible to inhibition by IL-6 and TGF beta. As a result, Th17 development is strongly favored, the threshold for TGF beta requirement is lowered, and IL-6 drives Th17 differentiation, elucidating a critical role for T-bet in directing T cell differentiation to Th1 vs Th17. In contrast to IL-6 plus TGF beta-driven Th17, IIL-6-driven Th17 cells do not express IL-10 and they induce a more intense colitis. Naive CD4 T cells deficient in Stat6 and T-bet also induce a Th17-dominant colitis development in vivo. Our data provide new insights into the choice between Th1 and Th17 development and their roles in autoimmunity. The Journal of Immunology, 2008, 181: 8700-8710.

引用

页码：8700 / 8710

页数：11

共 43 条

[1] T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells [J].

Afkarian, M ;

Sedy, JR ;

Yang, J ;

Jacobson, NG ;

Cereb, N ;

Yang, SY ;

Murphy, TL ;

Murphy, KM .

NATURE IMMUNOLOGY, 2002, 3 (06) :549-557

[2] Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 [J].

Aggarwal, S ;

Ghilardi, N ;

Xie, MH ;

de Sauvage, FJ ;

Gurney, AL .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1910-1914

[3] Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis [J].

Bettelli, E ;

Sullivan, B ;

Szabo, SJ ;

Sobel, RA ;

Glimcher, H ;

Kuchroo, VK .

JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (01) :79-87

[4] TH-17 cells in the circle of immunity and autoimmunity [J].

Bettelli, Estelle ;

Oukka, Mohamed ;

Kuchroo, Vijay K. .

NATURE IMMUNOLOGY, 2007, 8 (04) :345-350

[5]

Betti M, 2006, ANN ONCOL, V17, P235

[6] The immunological and genetic basis of inflammatory bowel disease [J].

Bouma, G ;

Strober, W .

NATURE REVIEWS IMMUNOLOGY, 2003, 3 (07) :521-533

[7] Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis [J].

Chitnis, T ;

Najafian, N ;

Benou, C ;

Salama, AD ;

Grusby, MJ ;

Sayegh, MH ;

Khoury, SJ .

JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (05) :739-747

[8] Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiation [J].

Diehl, S ;

Chow, CW ;

Weiss, L ;

Palmetshofer, A ;

Twardzik, T ;

Rounds, L ;

Serfling, E ;

Davis, RJ ;

Anguita, J ;

Rincón, M .

JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (01) :39-49

[9] Mechanism of transforming growth factor β-induced inhibition of T helper type 1 differentiation [J].

Gorelik, L ;

Constant, S ;

Flavell, RA .

JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (11) :1499-1505

[10] Cutting edge:: TGF-β inhibits Th type 2 development through inhibition of GATA-3 expression [J].

Gorelik, L ;

Fields, PE ;

Flavell, RA .

JOURNAL OF IMMUNOLOGY, 2000, 165 (09) :4773-4777

← 1 2 3 4 5 →